Remembering the IceBreakers of the Xijun

TianshiLi Holding Stakes Group Chairman Yu Xijun firm walkers will eventually usher in a fruitful harvest, thick and thin-haired Tianshili ushered in a milestone in the history of development, the internationalization of modern Chinese medicine made a major breakthroughFrom product internationalization to enterprise internationalization, in the past 20 years, The Bohai Coast Tianshi li from Tianjin to the whole country, from China to the worldIts development experience is of great significance to Chinese medicine enterprises in China who are struggling to "go out""Internationalization is the only criterion for testing the modernization of Traditional Chinese medicine"Going abroad, going to the world, and realizing the internationalization of enterprises, is not only the inherent requirements of their own development, but also the great dream of tianshili to benefit mankind with ancient Chinese medicine." This is the unshakable belief of the Yan Xijun, and also the key to the success of the interpretation of Tian ShiliIn 1997, The Mofon Dansin Pill became the first modern Chinese medicine in China to apply for clinical research (IND) for new drugs from the United States Food and Drug Administration (FDA), the first global dealer conference of Tianshili was held in Malaysia in 2007, and Tianshili's successful international marketing brought the reputation of "Oriental God Dan" to The Fufang Dansin Pill, and in August 2010, Tianshili announced the successful completion of the FDA II clinical trialWang Qiang, director of the State Administration of Traditional Chinese Medicine, said that summing up the experience of Tianshili's development is of great significance to Chinese medicine enterprises in China who are struggling to "go out"TianshiLi HoldingS Group Chairman Of the Board of Directors of the "Bold" to break into the United States FDA "bold" - this is the army in the army when the creation of TianshiLi, his comrades gave him a nickname"Bold courage", this is the media reports that the Zhai Xijun once used the title when he started his businessThe army had a lot of courage, but no one knew how much he wasIn July 1996, the Yan XiJun made a decision that shocked many people, and even some were still incredulous about his spiritBut it is precisely because of this major decision that has had a profound impact in the history of enterprise development that the tianshi has changed radicallyThe decision was to respond to the national call to send the compound dansin droppills to the United States to apply for a clinical study of the FDA's new drug, and thus to qualify for the U.SmarketPrior to this, no Chinese medicine preparation has ever filed an application with the FDABecause has not been approved by the European and American drug regulatory departments, Chinese medicine has not been able to be as a drug in Europe and the United States mainstream market salesIn 1996, when Tianshili was still a small pharmaceutical factory, only three years after its establishment At the end of 1993, The compound Dansan drop pills only obtained the national new drug certificate and production code, in the domestic market just started Under such conditions, bravely the United States FDA, is not known to the sky thick, or the newborn calf is not afraid of tigers? Is it far-sighted, proactive, or dare to be the first to the world? "I didn't think so much" a few years later, when Yan Xijun told reporters, "I am a soldier, the country needs me to rush; "The Yan Xijun saw the decision of the year as his own division of affairs, is an inevitable choice Today, when we look back at his decision, we will find that there is responsibility and responsibility behind the strong sense of identity of the Yan Xi Army "Every time my mood is complicated, " said Yu Xijun, a representative of the National People's Congress and a national model of labor, "to carry forward Chinese medicine is our immediate and urgent task." "Revival of Traditional Chinese Medicine is the Chinese dream of the Yan Xijun Years like songs, now in the tall Yan Xijun body, both the military's boldness, but also the modern entrepreneur's shrewd, elegant and introverted Decoding Tian Shili, you must understand the Yan Xijun, you know every time he to the critical moment, that fearless spirit of boldness from where In August 2010, when the Fudan ginseng pills passed the FDA Phase II clinical trial, Zhao Baidou, then deputy director of the National Population and Family Planning Commission, came to congratulate him Zhao Baidou received his Ph.D from Cambridge University in the United Kingdom, was the National Committee of Overseas Experts on New Drug Research and Development, and has a strong sense of distress about the international plight of Chinese medicine, so he is more eager to make a breakthrough in the internationalization of Chinese medicine Zhao Baidou said that the implementation of the strategy of internationalization of Chinese medicine is not only the inevitable requirement of international competition and preemption of industrial commanding heights, but also a profound reflection of China's medical industry is not willing to report to the country And Yan Xijun is one of the outstanding representatives of The Chinese medical profession The first step in the internationalization of Chinese medicine is to obtain the approval of the international authoritative drug regulatory body, so that it can enter the mainstream pharmaceutical market as a drug In the spring of 1996, the State Science and Technology Commission, the State Administration of Traditional Chinese Medicine and other organizations to visit the United States, and the United States FDA contact The company has just made a difference, with more than a dozen other entrepreneurs to go out together "eye-opening" This is the first time that Yu Xijun went to the United States, in addition to a few simple changes of clothes, his luggage is a box of compound Dansan drops The delegation was led by Ren Dequan, then deputy director of the State Administration of Traditional Chinese Medicine, who actively advocated the modernization of Chinese medicine in China, organized and implemented the Quality Management Practice (GMP) for the production of chinese medicine industry, put forward and implemented standardized cultivation of raw materials (GAP) in the Chinese medicine industry, and put forward and implemented fingerprint mapping in the quality control of Chinese medicine He also participated in the three-round round of negotiations on intellectual property between China and the United States as a member of the Chinese government delegation, and was specifically responsible for negotiations in the field of medicine It was the negotiations and communication between the Chinese and American governments that led to the FDA opening the door to the declaration of Chinese medicine, and the visit of Chinese traditional chinese medicine entrepreneurs to the United States The first visit to the United States left a memorable memory for the Yan Xijun Before setting off, he organized his employees to work overtime and print out the English instructions for the Fudan Sansan drop pills, looking forward to opening up the U.S market Can xijun Wan did not think, because Chinese medicine in Europe and the United States did not obtain the identity of drugs, even pharmacies can not enter, according to U.S law, Chinese medicine can only be in the form of health care products, food or food supplements, distribution channels only concentrated in chinese Chinese medicine shops, grocery stores, not allowed to mark functional efficacy, not allowed to advertise, not to mention enter the local mainstream health insurance market He later recalled: Most of the medicine we brought with us came back The compound Dansan drop pills are still lucky, several agents saw this small drop pill is very surprised, with a try attitude to buy a box of medicine This trip to the United States, give us to go to the entrepreneurs a very big blow, we did not expect that Chinese medicine in the international community, it is so embarrassing position What's going on? The Yan Xijun has a heart and ache, and more pain During his visit to the United States, he often fell into contemplation: the absence of drug status in Europe and the United States was undoubtedly the primary issue But he sensed vaguely that the key was much more than that In the years that followed, the thinking and anxiety about the situation of Chinese medicine abroad was often accompanied by the Yan Xijun On the same day Shili is committed to developing the domestic market, in the face of the challenge of "foreign Chinese medicine", his ideas gradually become clear, the internationalization of Chinese medicine and modernization is inseparable, to promote the Chinese medicine culture and market-oriented closely related According to the World Health Organization, the current global plant medicine market is about 60 billion U.S dollars, of which the Chinese medicine market accounts for about half China is a large producer of Chinese medicine, foreign enterprises use 80% of the raw materials of Chinese medicine from China, but China's exports of Chinese medicine less than one-tenth of the global Chinese medicine market, according to the Chinese Medical and Health Products Import and Export Chamber of Commerce statistics, in 2012 the export of Chinese medicine products is only 2.5 billion U.S dollars.